This year again, Ondalys will be present at the France Bioproduction 2025 Congress, organized by Polepharma and Medicen Paris Région on March 19 & 20, 2025 at the Palais des congrès de Tours.
With Igor Chourpa, Professor-Director of the Nano-Medicine and Nano-Probe Laboratory (NMNS) at the University of Tours and Thomas Saillard, Upstream Bioprocess Engineer at Servier, Sylvie Roussel will present an oral presentation entitled:
PAT for bioprocess : implementation of Raman probes and Chemometrics modelling
From the collaborative CLIMBIN project bringing together NMNS, LRGP, Servier, Ondalys and INDATECH -Chauvin Arnoux, the work presented at CFB2025 will highlight the consortium’s progress in terms of innovative solutions for real-time control of suspended cell cultures (CHO, etc.) in bioreactors.
Within this project, the Ondalys team was in charge of predicting Critical Process Parameters (CPPs) and Critical Quality Attributes (CQAs) using Machine Learning (ML) algorithms.
👉 ALL you need to know about France Bioproduction Congress 2025
With extensive experience in supporting biotechnology and biopharmaceutical manufacturers, the Ondalys team offers its expertise to address issues related to monitoring and optimizing cell bioproduction (yeasts, CHO, antibodies, etc.).
Indeed, cell cultures in bioreactors generate large databases grouping together process parameters and online measurements (oxygen, pH, data from online analyzers such as Raman spectroscopy, at-line measurements, etc.).
The interest in using data analysis and Machine Learning methods to process these large and complex databases, in order to best characterize the behavior of the bioreactor, is now proven.
Watch Sylvie Roussel interview
during the 2023 France Bioproduction Congress
To learn more about Machine Learning and Data Analytics for the Biopharma and Biotech industries,
check out our dedicated pages.
Polepharma is the 1st pharmaceutical cluster and aims to structure the French (bio)pharmaceutical industrial sector by supporting its transformation towards the Industry of the Future.
The mission that Polepharma has set itself revolves around 3 objectives:
- Make France the best place in the world to develop & produce (bio)medicines.
- Manufacture quality treatments in France in the best conditions and secure public health, contribute to employment and local economies.
- Promote industrial cooperation between territories and laboratories, suppliers, schools, collectives, experts, talents, etc.
